A Study to Evaluate Efficacy and Safety of MK-7240 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

Conditions: Ulcerative Colitis Interventions: Drug: IV MK-7240; Drug: IV Placebo; Drug: SC MK-7240; Drug: SC Placebo Sponsors: Merck Sharp& Dohme LLC; PPD, Part of Thermo Fisher Scientific Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials